A mechanistic model of pure and lipidic α-synuclein aggregation for advancing Parkinson’s therapies
Abstract Alpha-synuclein (aSyn) plays a crucial role in Parkinson’s disease, with various aggregates proposed as pathogenic triggers and therapeutic targets. However, anti-aSyn aggregation compounds often fail due to limited knowledge of the underlying molecular basis. In particular, interactions wi...
Saved in:
| Main Authors: | Elena Righetti, Luca Marchetti, Enrico Domenici, Federico Reali |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | Communications Chemistry |
| Online Access: | https://doi.org/10.1038/s42004-025-01558-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phosphorylated α-Synuclein-Copper Complex Formation in the Pathogenesis of Parkinson’s Disease
by: Juan Antonio Castillo-Gonzalez, et al.
Published: (2017-01-01) -
MicroRNAs: Game Changers in the Regulation of α-Synuclein in Parkinson’s Disease
by: Liang Zhao, et al.
Published: (2019-01-01) -
A novel approach to detecting plasma synuclein aggregates for Parkinson’s disease diagnosis
by: Hyo Rim Ko, et al.
Published: (2025-07-01) -
Parkinson’s Disease: A Narrative of the Evolving Understanding of the Role of α-Synuclein in Screening
by: Alan D. Kaye, et al.
Published: (2024-11-01) -
Nanotherapeutic Approaches of Interleukin‐3 to Clear the α‐Synuclein Pathology in Mouse Models of Parkinson's Disease
by: Wenlong Zhang, et al.
Published: (2024-11-01)